Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Harnessing the platelet

L G Futterman1, L Lemberg

  • 1Department of Medicine, University of Miami School of Medicine, Fla, USA.

American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
|September 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Effectiveness and patient tolerance of screening colonoscopy -- first results].

Zeitschrift fur Gastroenterologie·2004
Same author

Herbal or complementary medicine: fact or fiction?

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
Same author

Brugada.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
Same author

Heart failure: update on treatment and prognosis.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
Same author

The critical role of the endothelial cell in acute coronary events.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
Same author

The mysteries of the human genome uncovered--medicine is changed forever.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
Same journal

Predicting Nonrecovery of Muscle Strength in Critically Ill Patients with Intensive Care Unit-Acquired Weakness.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2026
Same journal

Ventilator-Associated Pneumonia According to Chlorhexidine Oral Care Exposure in Patients With New Tracheostomy.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2026
Same journal

Incidence of Nasogastric Tube-Related Pressure Injuries in Intensive Care Unit and Internal Medicine Ward.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2026
Same journal

Beyond Survival: Lessons From a Research Journey in Critical Care Recovery Science.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2026
Same journal

Clinical Utility of β-Hydroxybutyrate vs Anion Gap to Define Resolution of Diabetic Ketoacidosis.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2026
Same journal

Exploring Intensive Care Unit Nurses' Resilience During the COVID-19 Pandemic: A Qualitative Research Study.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2026
See all related articles

Aspirin significantly reduces cardiovascular events by inhibiting platelet aggregation. New drugs targeting the platelet fibrinogen receptor GP IIb/IIIa offer improved specificity and safety for treating arterial thrombosis.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Pharmacology

Background:

  • Platelets play a critical role in cardiovascular disease, particularly in arterial thrombosis.
  • Aspirin's antiplatelet effect demonstrated a 25% reduction in myocardial infarction, stroke, and vascular death.

Observation:

  • Platelet aggregation is primarily mediated by the platelet fibrinogen receptor, GP IIb/IIIa.
  • GP IIb/IIIa receptor binding to fibrinogen is the final common pathway for thrombus formation.

Findings:

  • Abciximab, an early GP IIb/IIIa inhibitor, effectively reduced thrombotic complications in acute coronary events.
  • Newer synthetic peptide GP IIb/IIIa inhibitors exhibit enhanced specificity, are nonimmunogenic, and cause less bleeding.

Implications:

Related Experiment Videos

  • Targeting platelet action is crucial in managing acute coronary events and arterial thrombosis.
  • Oral GP IIb/IIIa inhibitors are anticipated to become standard therapy for unstable angina.